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trans-Golgi networkencodes ﬁve genes that do not have herpes simplex virus homologs. One of these
genes, VZV open reading frame 1 (ORF1), encodes a membrane protein with a hydrophobic domain at its
C-terminus that is predicted to be the transmembrane domain. However, the detailed characterization of ORF1
protein in infected cells has not been reported. Here, we produced mono-speciﬁc antibodies against ORF1
protein and characterized the gene products in infected cells. Western blot analyses showed the ORF1
polypeptides had apparentmolecular masses of approximately 14–17 kDa. Furthermore, ORF1was found to be
a phosphoprotein by immunoprecipitation assay. In immunoﬂuorescence assays, the VZV ORF1 protein was
detected at both the plasma membrane and trans-Golgi network in both VZV-infected and ORF1-transfected
cells.Moreover, ORF1 proteins associatedwith each other to formhomodimer, andwere incorporated into viral
particles. The C-terminal hydrophobic domain was required for the association of ORF1 with the membrane
structures, indicating that ORF1 protein is anchored to the membrane thorough its C-terminus, which is a
transmembrane domain. Because ORF1 possesses a C-terminal transmembrane domainwithout anN-terminal
signal sequence for its translocation to the ER lumen, ORF1 can be classiﬁed as a tail-anchored membrane
protein. These results show that the N terminus of ORF1 protein faces the cytoplasm in infected cells and the
tegument region in mature virions.
© 2008 Elsevier Inc. All rights reserved.Introduction
Varicella-zoster virus (VZV) is a member of the alphaherpesvirus
subfamily and causes chickenpox (varicella) and shingles (herpes
zoster). VZV often persistently infects the dorsal root ganglia and is
sometimes reactivated from the latent to the lytic state, resulting in
shingles in aged and immunosuppressed individuals (Arvin, 1996).
Functions have been assigned to many of the VZV gene products by
the direct analysis of VZV proteins and homology analysis between
VZV and Herpes simplex virus type 1 (HSV-1), which is the prototype
of the alphaherpesviruses. HSV-1 and HSV-2 are prevalent human
pathogens typically causing recurrent labial herpes and genital
herpes, respectively. Although these genomes have a similar structural
organization and over 90% of the genes of VZV have HSV homologs,
these viruses cause different diseases. These differences might be due
to the functions of VZV unique genes.
VZV has a large double-stranded DNA genome of approximately
125 kb that encodes at least 70 unique genes, most of which are
conserved in HSV. However, open reading frames (ORFs) 1, 2, 13, 32,
and 57 do not have obvious HSV-1 counterparts (Cohen et al., 2007).l rights reserved.Only one of these genes, ORF13, has been shown to encode a functional
protein, viral thymidylate synthetase (Thompson et al., 1987).
Although each of these VZV unique genes is dispensable for VZV
replication in cell culture (Cohen and Seidel, 1993, 1995; Cox et al.,
1998; Reddy et al.,1998; Sato et al., 2002), theymay play unique role(s)
in VZV replication and pathogenesis.
VZV ORF1 is predicted to encode a protein containing 108 amino
acids (Davison and Scott, 1986), and epitope-tagged ORF1 has been
identiﬁed as a membrane protein in infected cells (Cohen and Seidel,
1995). A recombinant virus that does not express ORF1 shows no
growth impairment in cell culture (Cohen and Seidel, 1995).
Furthermore, an ORF1-null mutant obtained by the bacterial artiﬁcial
chromosome system shows no growth impairment in cultured MeWo
cells or in severe combined immunodeﬁcient mice with human tissue
zenograft (SCID-hu mice) (Zhang et al., 2007).
VZV ORF1 is a membrane protein (Cohen and Seidel, 1995), with a
C-terminal hydrophobic tail sufﬁcient for a transmembrane domain
(TMD) and no N-terminal signal sequence. These are features of tail-
anchored (TA)membraneproteins (Borgese et al., 2003; High andAbell,
2004; Kutay et al., 1993;Wattenberg and Lithgow, 2001). Themembers
of this class ofmembrane proteins have no signal sequence, but possess
one hydrophobic segment near the C terminus that anchors the protein
to the membrane and orients the entire functional N-terminal portion
toward the cytoplasm. TA proteins are an important class of membrane
Fig. 2. The phosphorylation of ORF1 protein. MeWo cells weremock-infected or infected
with strain pOka by cell-to-cell spread and labeled with [32P]-orthophosphate (lanes 1
and 2) or [35S]-methionine and [35S]-cysteine (lanes 3 and 4) from 32 hpi to 48 hpi. Cell
lysates were immunoprecipitated with anti-ORF1 antiserum. Immunocomplex were
separated by SDS-PAGE using 4–12% gradient gel. Positions of molecular mass markers
(in kilodaltons) are indicated on the right.
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Abell, 2004), the SNARE proteins involved in vesicle trafﬁcking (Jahn
and Scheller, 2006), the Bcl-2 family involved in apoptosis (Walensky,
2006), and several subunits of the mitochondrial and endoplasmic
reticulum (ER) protein translocation channels (Osborne et al., 2005;
Rehling et al., 2004). These TA proteins are released from the ribosome
and inserted into the lipid bilayer by a signal recognition particle-
independent pathway.
In the present study, we prepared anti-ORF1 mono-speciﬁc anti-
bodies in rabbits and used them to characterize the ORF1 protein. Our
observations suggest that ORF1 is a TA protein that localizes to both
the plasma membrane and the trans-Golgi network (TGN) in VZV-
infected or ORF1-transfected cells. Moreover, the ORF1 proteins asso-
ciated with each other to form homodimer, which were incorporated
into viral particles.
Results
The C-terminus of ORF1 is a predicted transmembrane domain
The ORF1 protein contains a C-terminal hydrophobic domain from
amino acids 77 to 99. A Kyte and Doolittle hydrophobicity plot (Kyte
and Doolittle, 1982) and the algorithm of SOSUI (Hirokawa et al., 1998)
classiﬁed ORF1 as having a single TMD at its C-terminus without an
N-terminal cleavage signal sequence (data not shown). These results
show that ORF1 has the features of a TA protein.
Expression of ORF1 protein in VZV-infected cells and VZV virions
To verify that the ORF1 gene product is expressed in VZV-infected
cells, rabbit antibodies against the VZV ORF1 protein were generated.
TheN-terminal 76 amino acids of ORF1were expressed as a GST-fusion
protein, GST-ORF1, in E. coli. The GST-ORF1 protein was then puriﬁed
with Glutathione–Sepharose beads and used to immunize two rabbits.
One of the resulting antisera speciﬁcally reacted with at least three
polypeptides in pOka-infected MeWo cell lysates by Western blotting
(Fig. 1A). The apparent molecular masses of these polypeptides wereFig. 1. Time-course of ORF1 protein synthesis in VZV-infected cells and identiﬁcation of
ORF1 protein in virions. (A) MeWo cells weremock infected or infectedwith strain pOka
by cell-to-cell spread and harvested at 24 or 48 hpi. Samples were separated by SDS-18%
PAGE and analyzed by Western blotting with anti-ORF1 mono-speciﬁc antibodies.
Positions of molecular mass markers (in kilodaltons) are indicated on the left. (B) The
whole-cell lysates of pOka-infected MeWo cells (WCL) and virion fractions puriﬁed by
Histodenz (Hist) and CsCl (CsCl) gradients were separated by SDS-18% PAGE and
analyzed by Western blotting with antibodies to viral and cellular markers.approximately 14–17 kDa. This antiserumdid not reactwith proteins in
mock-infected cell lysates (Fig. 1A). Moreover this antiserum speciﬁ-
cally reacted with proteins in both VZV-infected (Fig. 3E) and ORF1-
transfected cells (Fig. 4B), while it did not react with proteins in mock-
infected cells (Fig. 3F) by immunoﬂuorescence assay as well. These
results indicated that this antiserum speciﬁcally reactedwith the ORF1
protein; therefore, it was used as an anti-ORF1mono-speciﬁc antibody
in further experiments.
To determinewhether ORF1 protein is a virion component, puriﬁed
VZV virions were analyzed by Western blotting. VZV virions were
puriﬁed by the sedimentation velocity method using Histodenz
gradients and a CsCl density gradient as described inMethods. Because
a CsCl density gradient separates materials according to density,
mature virions can be clearly separated from particles that do not
contain nucleocapsids. As shown in Fig. 1B, ORF1 was detected in both
virion fractions, suggesting that ORF1 is incorporated into mature VZV
virions. An envelope glycoprotein B (gB) and a tegument proteinORF49
were also detected in both the Histodenz- and CsCl-puriﬁed virion
fractions (Fig. 1B). ORF16, the homolog of HSV UL42 (Cohen et al.,
2007), which is not a structural protein, was not detected in either the
Histodenz- or CsCl-puriﬁed virion fraction (Fig. 1B). EEA1, which is a
180-kDa hydrophilic peripheral membrane protein that localizes to
early endosomes, was also not detected in the virion lysates (Fig. 1B).
These results indicated that these virion fractions were not contami-
nated with non-structural viral proteins or cytoplasmic membranes.
Post-translational modiﬁcation of ORF1
In order to determine the post-translational modiﬁcation of ORF1
in infected cells, radiolabeling experiments were performed. The 32P-
or 35S-labeled proteins from pOka- or mock-infected MeWo cells were
immunoprecipitated with anti-ORF1 antibody. As shown in Fig. 2, the
similar size of protein was precipitated with anti-ORF1 antibody in
35S- and 32P-labeled lysates from infected cells (arrowheads in lanes 1
and 3 of Fig. 2), indicating that ORF1was phosphorylated. On the other
hand, ORF1 was resistant to PNGase-F and Endo-H glycosidases
although ORF1 has a putative N-glycosylation site at amino acid
position 35 (data not shown).
Intracellular localization of ORF1 protein in VZV-infected cells
MeWo cells infected with cell-free VZV were ﬁxed at various times
postinfection, and the intracellular localization of ORF1 protein was
examined by indirect immunoﬂuorescence assay. At 48 hpi, ORF1 was
detected at the cell rim and the perinuclear region of the cytoplasm
(Fig. 3A). The staining pattern of ORF1 at the cell rimwas similar to that
of Cadherin (Fig. 3D), consistent with ORF1 protein being localized to
the plasma membrane. Furthermore, ORF1 protein was partially colo-
calized with gE at the perinuclear region of the cytoplasm (Fig. 3A).
Considering the association of ORF1 with VZV virions, the perinuclear
localization may indicate ORF1 protein accumulation at the viral
assembly compartment. To examine the association of ORF1 with
intracellular compartments, VZV-infected cells were analyzed by a
Fig. 3. Intracellular localization of ORF1 protein in VZV-infectedMeWo cells. MeWo cells infected with cell-free pOka at anm.o.i. of 0.01 were ﬁxed at 48 hpi and subjected to confocal
microscopic analysis. Cells were double-labeled for ORF1 and the VZV glycoprotein gE (A), the cis-Golgi marker GM130 (B), the TGN marker TGN46 (C), or the plasma membrane
marker Cadherin (D); nuclei were stained with Hoechst 33342. Scale bar: 3.75 µm. Lower magniﬁcation of pOka- (E) or mock-infected (F) MeWo cells labeled with anti-ORF1 was
shown. Scale bar: 20 µm.
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colocalize with a marker for the cis-Golgi, GM130 (Fig. 3B). Although
the intensity of TGN46 was very weak in infected cells, ORF1 protein
partially colocalized with TGN46, a marker of trans-Golgi network
(TGN), at the perinuclear region of cytoplasm (Fig. 3C arrowhead). Since
the VZV assembly compartment contains TGN-derived vesicles in
which secondary envelopment has been shown to occur (Hambleton
et al., 2004), this result suggests that ORF1 protein may localize to the
assembly compartment.
Intracellular localization of ORF1 protein in transiently transfected cells
To determine the intracellular localization of ORF1 protein in the
absence of other viral proteins, pCAGGS-ORF1-transfected MeWo cells
were analyzed by immunoﬂuorescence assay. In transiently transfected
cells,ORF1proteinwasdetectedat the cell rim in aﬁne speckledpattern,
and at the perinuclear region of the cytoplasm (Fig. 4A). The localization
to the cell rim indicated that ORF1 protein was located on the plasma
membrane, because the staining pattern of ORF1 was similar to that of
Cadherin (Fig. 4Ad). ORF1partially colocalizedwithp230 (Fig. 4Ab), but
not GM130 (Fig. 4A a). Interestingly, TGN46 was redistributed through-
out the cells and co-localizedwithORF1asﬁne speckledpattern and cellrim (Fig. 4A c). These results suggest thatORF1protein is associatedwith
the plasma membrane and membranous structures of the TGN when
expressed in the absence of other viral factors.
To determine whether the C-terminal hydrophobic region of ORF1
affects the localization of protein, a C-terminal-deleted mutant was
constructed and its localization in transfected MeWo cells was
analyzed. HA-tagged full-length ORF1 protein localized to the same
sites in transfected cells as the wild-type ORF1 protein (Fig. 4B), while
HA-ORF1(1–76) protein, the C-terminal hydrophobic domain-deleted
mutant, was distributed diffusely throughout the cells (Fig. 4B). This
result suggests that the C-terminal domain of ORF1 is essential for its
association with membranous structures in the cytoplasm.
The N-terminus of ORF1 faces the cytoplasm
According to the model of secondary envelopment (Mettenleiter,
2002), the N-terminal region of ORF1would be found in the cytoplasm
of infected cells and in the tegument of virions. To examine whether
ORF1 has such an orientation, we performed a membrane two-hybrid
assay and protease protection assay.
The membrane two-hybrid assay is based on the reconstitution of
split ubiquitin (Johnsson and Varshavsky, 1994; Stagljar et al., 1998).
Fig. 4. Intracellular localization of ORF1 in cells transiently expressing it. (A) ORF1-transfected MeWo cells were ﬁxed at 24 h post-transfection and subjected to confocal microscopic
analysis. Cells were double-labeled for ORF1 and the cis-Golgi marker GM130 (a), the TGNmarker p230 trans-Golgi (p230) (b), TGN46 (c), or the plasma membrane marker Cadherin
(d); nuclei were stained with Hoechst 33342. Scale bar: 3.75 µm. (B) MeWo cells were transfected with HA-ORF1 or HA-ORF1(1–76), in which the C-terminal hydrophobic domain
was deleted, ﬁxed 24 h post-transfection, and analyzed by confocal microscopy. Cells were double-labeled with anti-HA and anti-ORF1 antibodies; nuclei were stained with Hoechst
33342. Scale bar: 15 µm.
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ubiquitin (Cub) and an artiﬁcial transcription factor (LexA-VP16). The
yeast membrane protein control, Alg5, was expressed as a fusion with
the wild-type (Alg5-Nubwt) or mutated N-terminal half of ubiquitin
(Alg5-Nub(I3G)). The Nub domain of these fusion proteins localizes to
the cytoplasmic region of membranous structures in transformed
yeast cells. If the N-terminal domain of ORF1were oriented toward the
cytoplasm, Cub and Nubwt would be reconstituted because of their
afﬁnity for each other, and would spontaneously reassemble to form
whole ubiquitin. If this occurred, the LexA-VP16 domain of the ORF1fusion protein would be released and transported into the nucleus,
and LexA-VP16-Cub-ORF1 and Alg5-Nubwt co-transformed yeast cells
would grow on the selective medium. In contrast, Alg5-Nub(I3G)
cannot be reconstituted, because the point mutation in Nub abolishes
its afﬁnity for Cub; thus, LexA-VP16-Cub-ORF1 and Alg5-Nub(I3G) co-
transformed yeast would not be able to grow on the selection
medium. In the case where the N-terminal region of ORF1 was
oriented to the extracellular region and ER lumen, Cub and Nubwould
not be reconstituted in the co-transformed yeast, and the co-trans-
formed yeast would not be able to grow on the selective medium. As
Fig. 6. Dimerization of ORF1 proteins. (A) Schematic representation of epitope-tagged
ORF1 constructs. The N-terminal HA tag and FLAG tag are indicated as a dotted and
hatched box, respectively. The transmembrane domain is indicated as a gray box.
(B) 293T cells were transfected with epitope-tagged ORF1 plasmids, harvested, and
lysed in TNE-1% TX100 buffer. Cell lysates were immunoprecipitated by an anti-HA or
-FLAG monoclonal antibody with protein-G Sepharose. The cell lysates or immune
complexes were then separated by SDS-18% PAGE and analyzed by Western blotting
with an anti-HA or -FLAG monoclonal antibody.
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efﬁciently on the selection medium than did the Alg5-Nub(I3G) co-
transformed yeast. This result indicates that the N-terminal region of
ORF1 is oriented toward the cytoplasm.
To conﬁrm these observations, we performed a protease protection
assay as described in Methods. Histodenz-puriﬁed VZV virions were
digested with Proteinase K (ProK) in the presence or absence of
detergent and analyzed by Western blotting. In this assay, proteins
outside of the envelope are sensitive to ProK both in the presence and
absence of detergent, but proteins inside the envelope are sensitive
only in the presence of detergent (Fig. 5B). An envelope glycoprotein,
gB, was sensitive to ProK both in the presence and absence of
detergent (Fig. 5C), indicating that gB is on the surface of virions. The
gB band was digested more easily in the presence of detergent, which
may indicate that the detergent affected the structure of gB to make it
more easily digested by ProK. As expected, ORF1 proteinwas sensitive
to ProK only in the presence of detergent (Fig. 5C), indicating that the
N-terminal region of ORF1 faces the tegument region of virions.
ORF1 molecules form a homodimer
Using the membrane yeast two-hybrid system, we detected an
interaction between ORF1 molecules, LexA-VP16-Cub-ORF1 and Nub
(I3G)-ORF1 (data not shown). Therefore, to verify the results from
yeast, we examined the interaction between HA-ORF1 and FLAG-ORF1
in a transient expression system by co-immunoprecipitation assay.
ORF1 fusion protein expression plasmids in which the HA or FLAG
sequence was tagged at the N-terminus of ORF1 (Fig. 6A), were
transfected into 293T cells, and the cells were harvested at 24 h post-
transfection. As shown in Fig. 6B, both the HA and FLAG fusion
proteins were detectable in cell lysates, and HA-ORF1 and FLAG-ORF1
proteins were speciﬁcally co-precipitated with FLAG-ORF1 and HA-Fig. 5. Topology of the ORF1 protein. (A) Yeast cells were transformed with ORF1 bait
plasmid and pAI-Alg5 (Nub(wt)) or pDL2-Alg5 (Nub(I3G)) as prey. Transformed yeast was
grown on selective medium as indicated. Abbreviations of depleted nutrients in selective
medium: L, leucine;W, tryptophan;H,Histidine; A, adenine. (B) Schematic representation
of the protease protection assay. In this assay, the viral envelope is permeabilized by a
detergent such as Triton X-100. Proteinase K (ProK) digests only protein on the surface of
the envelope in the absence of detergent, and digests the proteins inside the envelope in
the presence of detergent. (C) Puriﬁed virionswere digestedwith ProK in the presence (+)
or absence (−) of 1% Triton X-100 (TX100). The amount of ProKwas gradually increased as
indicated. Samples were separated by SDS-18% PAGE and analyzed by Western blotting
with anti-gB or anti-ORF1 mono-speciﬁc antibodies.ORF1 proteins, respectively (Fig. 6B lanes 8 and 12), indicating that the
ORF1 molecules associated with each other to form homodimer.
Discussion
The present study demonstrates that the ORF1 protein is associated
with VZV virions. The protease protection assay suggests that the
N-terminal side of ORF1 protein faces the tegument region of virions
and the C-terminus is associatedwith the viral envelope. Theseﬁndings
support the prediction ofORF1protein as a TAprotein. ORF1 localized to
the plasma membrane and the perinuclear region of cytoplasm in
infected cells, which may have been herpesvirus assembly compart-
ments. The ORF1 localization in the assembly compartment would be
consistent with the detection of ORF1 protein in puriﬁed virions.
ORF1 is encoded at the end of UL region of VZV genome (Davison
and Scott 1986). Another gene, ORF0, a putative membrane protein, is
encoded next to ORF1 (Kemble et al., 2000, Zhang et al., 2007). While
they are encoded on opposite strands, ORF0 and ORF1 share the
features of TA protein. Moreover HSV-1 and HSV-2 UL56, the Equine
herpesvirus type-1 (EHV-1) gene1, EHV-1 gene 2, and PRV ORF-1
share the hydrophobicity proﬁle of TA proteins (Koshizuka et al., 2002,
Baumeister et al., 1995, Telford et al., 1992), indicating that TA proteins
are conserved at the end of UL region among alphaherpesviruses.
These genes might have been duplicated or deleted through evolution
as viruses adapted to their natural hosts.
ORF1 overexpressing cells showed themislocalization of TGN46. The
mislocalization of TGN46might not be detected in infected cells because
the expression levels of TNG46were reduced inVZV infected cells, or the
effect might be seen only in ORF1 overexpressing cells. The mislocaliza-
tion of TGN46 and the other TGN marker proteins has been reported in
GRIP domain-overexperssing cells (Yoshino et al., 2003). The over-
expression of GRIP domains leads to the disruption of the trans-Golgi
structure and interference with vesicle trafﬁcking (Yoshino et al., 2003).
To consider this, ORF1 might show a similar effect in transfected cells.
At present, the role of ORF1 in infected cells is uncertain. First, it is
possible that ORF1 plays a role in virion maturation. Since ORF1 is
classiﬁed as a dispensable gene in vitro (Cohen and Seidel,1995) and in
the SCID-humodel (Zhanget al., 2007), ORF1might play in cooperation
with other viral proteins involved in the secondary envelopment
process. Recently, it was reported that a PRV mutant simultaneously
lacking UL11 and glycoproteinM showed severely impaired secondary
envelopment, with these two proteins acting in a redundant fashion
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another viral gene(s) may be required to reveal the function of ORF1.
The second possible role of ORF1 is in vesicular transport. PRV
encoded TA protein, PRV US9, is required for the axonal localization of
PRV glycoproteins (Tomishima and Enquist, 2001). HSV-2 UL56 is
predicted to be involved in vesicular transport in infected cells
(Koshizuka et al., 2005). ORF1 was localized predominantly to the
plasmamembrane but PRV US9 or HSV-2 UL56 is not. To consider with
the difference of localization, ORF1 might play different part of
vesicular trafﬁcking from PRV US9 or HSV-2 UL56.
A third possibility is that ORF1 plays a role in cell-to-cell adhesion,
since ORF1 protein localizes to the plasmamembrane in infected cells.
In comparison with other alphaherpesvirus TA proteins, ORF1 is
unique in that it resides at the plasma membrane, suggesting that
ORF1 may associate tightly with the plasma membrane or with a
plasma membrane protein in infected and transfected cells. Consider-
ing ORF0, encoded next to ORF1, has been suggested to play a role in
altering the cell adhesion molecules in infected cells (Kemble et al.,
2000), ORF1 may have a similar function.
ORF1 homodimer was detected by co-immunoprecipitation assay.
Further studies to determine whether other proteins are contained in
this homodimer, and if so, to identify such ORF1 partner proteins, will
be important for determining the function of ORF1.
Methods
Cells and viruses
MRC-5 cells were cultured in Minimum Essential Medium (MEM)
supplemented with 10% fetal bovine serum (FBS). Human melanoma
cells (MeWo) were cultured in Dulbecco's modiﬁed Eagle's Medium
(DMEM) supplemented with 10% FBS. 293T cells were cultured in
DMEM supplemented with 10% FBS. The VZV parental Oka (pOka)
strain was used in this study and propagated in MRC-5 cells. The
infected cells were treated with 0.1% EDTA in PBS and sonicated, and
the lysates were spun at 500 ×g for 5 min at 4 °C. The supernatant was
transferred to new tubes for use as cell-free virus.
Plasmids
The E. coli expression plasmid pGEX-ORF1 was constructed by
amplifying the domains encoding ORF1 codons 1 to 76 by PCR from the
cDNAs of pOka-infected MRC-5 cells (Sadaoka et al., 2007) and cloning
the DNA fragment into pGEX-4T-1 (GE Healthcare Bio-science, Piscat-
away, NJ) in-framewith glutathione-S-transferase (GST). InpGEX-ORF1,
the initiation methionine of ORF1 was altered to alanine. The
mammalian expression plasmid pCAGGS-ORF1 was constructed by
amplifying the full-length ORF1 by PCR from the cDNAs of pOka-
infected MRC-5 cells (Sadaoka et al., 2007) and cloning the DNA
fragment into pCAGGS-MCS (Niwa et al., 1991). The pCAGGS plasmid
was kindly provided by Dr Miyazaki, Osaka University, Japan. To
generate pCAGGS-HAORF1 and pCAGGS-HAORF1(1–76), the HA epi-
tope sequence was ligated in-frame to the 5' region of full-length or
codons 1–76 ofORF1, and the resultingDNA fragmentswere cloned into
pCAGGS-MCS. The plasmid pFLAG-ORF1was constructed by amplifying
ORF1 by PCR and cloning the DNA fragment into pFLAG-CMV-6c
(Sigma-Aldrich, St. Louis, Mo) in-frame with the FLAG sequence. In the
N-terminally tagged ORF1 proteins, the initiation methionine of ORF1
was altered to alanine to eliminate the expression of normal ORF1. The
sequences of all plasmids were conﬁrmed by DNA sequencing,
Immunoﬂuorescence assay
MeWo cells grown on coverslips were subjected to infection or
transfection. Cells were infected with cell-free pOka for 1 h. At various
times after infection, cells were washed twice with ice-cold PBS andﬁxed with acetone–methanol for 1 h. In the case of transfected cells,
the cells were washed once with ice-cold PBS, ﬁxed with 4%
paraformaldehyde at 4 °C for 30 min, and then permeabilized with
PBS containing 0.1% Triton X-100 at 4 °C for 30 min. After the antibody
reaction, the cells were rinsed with PBS, mounted on glass slides, and
analyzed with the Leica confocal microscope system.
Antibodies
GST-ORF1(1-76) fusion protein was puriﬁed with Glutatione Sephar-
ose Beads (GEHealthcare Bio-Science) and used as an antigen to generate
rabbit anti-ORF1mono-speciﬁc antibodies. Anti-ORF1waspuriﬁedwitha
GST-ORF1 afﬁnity column to eliminate non-speciﬁc antibodies. The anti-
gB and anti-ORF16 rabbit antibodies were described previously (Sadaoka
et al., 2007). The anti-gE monoclonal antibody (mAb) was described
previously (Okuno et al., 1983). The anti-GM130mAb and anti-p230mAb
were purchased from BD Biosciences. The anti-pan-Cadherin mAb (CH-
19) was purchased from AbCam (AbCam, Cambridge, UK). The anti-
TGN46 sheep polyclonal antibodywas purchased fromAbD Serotec (AbD
Serotec, Oxford, UK). The anti-HA and anti-FLAG M2 mAbs were
purchased from Sigma-Aldrich. Alexa-Fluor 488 Goat anti-rabbit IgG
F(ab′)2 fragment, Alexa-Fluor 594 Goat anti-mouse IgG F(ab′)2 fragment,
Alexa-Fluor 488Goat anti-sheep IgGandAlexa-Fluor 594Goat anti-rabbit
IgG F(ab′)2 fragment were purchased from Molecular Probes. Goat anti-
rabbit-IgG HRP-conjugate and anti-mouse-IgG HRP-conjugate were
purchased from GE Healthcare Bio-Science.
Transfection
MeWo and 293T cells were transfected with Lipofectamine 2000
Reagent (Invitrogen, Carlsbad, CA).
Virion puriﬁcation
VZV virions were puriﬁed as described previously (Sadaoka et al.,
2007). After the second Histodenz gradient puriﬁcation, the virion
pellet was suspended in PBS and layered onto a continuous 10–40%
CsCl gradient, followed by centrifugation at 30,000 rpm for 48 h at 4 °C
with a P40ST rotor. The virion-containing fractions were collected by
needle, diluted with PBS, and pelleted by centrifugation at 27,000 rpm
for 2 h at 4 °C.
Metabolic labeling
The VZV pOka- or mock-infected MeWo cells in 25 cm2 dishes were
used for radio-labeling experiments. At 32hpi, the culturemediumwere
replaced by phosphate freemedium containing 1mCi of [32P]orthopho-
sphate or methionine and cysteine free medium containing 40 mCi of
L-[35S]methionine and L-[35S]cysteine.. At 48 hpi, cells were scraped into
lysis buffer (50 mM Tris–HCl [pH 7.5], 150 mMNaCl, 0.1% SDS, 1% Triton
X-100,1 mM EDTA) containing phosphataes inhibitors (Nakarai Tesque,
Kyoto, Japan) and protease inhibitors (Sigma). Cell lysates were
immunoprecipitated by anti-ORF1 antibody and the immunoprecipi-
tates were separated by SDS-PAGE using 4–12% gradient gel.
Protease protection assay
The protease protection assay was performed essentially as
described previously (Koshizuka et al., 2002).
Dual membrane two-hybrid assay
The yeast expression plasmid, pBT3-N-ORF1 or pPR3-N-ORF1 was
constructed by amplifying the full-length ORF1 and cloning the DNA
fragment into the SﬁI site of the pBT3-N or pPR3-N plasmid (Dual
systems Biotech, Switzerland). The full-length ORF1 was inserted into
295T. Koshizuka et al. / Virology 377 (2008) 289–295the bait expression vector pBT3-N downstream of, and in-frame with
LexA-VP16-Cub. The bait vector carried the LEU2 gene for auxotrophic
selection. The full-length ORF1 was also inserted into the prey expres-
sion vector pPR3-N downstream of, and in-frame with NubG. The prey
vector carried the TRP1 gene for auxotrophic selection. The sequences of
the ORF1-bait and ORF1-prey vectors were conﬁrmed by DNA se-
quencing. pAI-Alg5 or pDL2-Alg5 was used as a positive or negative
control to conﬁrm the bait construct that expressed the Cub-LexA-VP16
fusion protein in the correct orientation in the yeast membrane. The
bait and prey vectors were transformed into the yeast strain NMY-51
(MATa his3delta200 trp1-901 leu2-3, 112 LYS2::(lexAop)4-HIS3 ura3::
(lexAop)8-lacZ (lexAop)8-ADE2 GAL4) (Dualsystems Biotech), and
the yeast was grown on leucine–tryptophan double-selective plates
(SD-LW). Positive interactions were identiﬁed by the ability of yeast
to grow on leucine–tryptophan–histidine triple-selective (SD-LWH)
or leucine-tryptophan-histidine-adenine four-fold-selective plates
(SD-LWHA) in the presence of 10 mM 3-aminotirazole (3-AT).
Immunoprecipitation
293T cells were transfected with pHA-ORF1 and/or pFLAG-ORF1
using Lipofectamine 2000 (Invitrogen). The transfected cells were
washed twice with ice-cold PBS and lysed with TNE-1% TX100 buffer
(10 mM Tris–HCl pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100)
containing protease inhibitor cocktail (Sigma-Aldrich). Cell lysates
were spun at 800 ×g for 5 min to remove the nuclei and then at
100,000 ×g for 1 h at 4 °C to remove cell debris. The supernatants were
immunoprecipitated and the immunoprecipitates were subjected to
SDS-PAGE and analyzed by Western blotting.
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